Clinical Site

Boston, Massachusetts 02215

1 studies enrolling now · 16 studies all time

What they study most

Acne Inversa, Bipolar Depression, C3 Glomerulopathy (C3G), Cardiovascular Disease, Celiac Disease, Diabetic Foot Ulcer, Elevated Lipoprotein(a), Generalized Anxiety Disorder, Hidradenitis Suppurativa, Major Depressive Disorder, Respiratory Syncytial Virus Infections, Schizophrenia

Studies at this site

• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Completed
• A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa — Enrolling by invitation
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression — Completed
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• PRV-015 in Gluten-free Diet Non-responsive Celiac Disease — Completed
• Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder — Completed
• Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) — Completed
• Controlled Trial Evaluating Avacopan in C3 Glomerulopathy — Completed
• Lumateperone for the Prevention of Relapse in Patients With Schizophrenia — Completed
• Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa — Completed
• Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease — Completed
• Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed
• Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV) — Completed
• A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers — Status unconfirmed